Antibodies to cardiolipin (ACA) are markers for recurrent thrombosis and thrombocytopenial in systemic lupus erythematosus (SLE) and possibly for fetal loss in pregnant patients with the same disorder.2 They have been reported in association with cerebrovascular disease and more recently livedo reticularis4 in SLE. An association between livedo reticularis and cerebrovascular disease has been recorded. 5 6 Most reported associations, however, have been with highly selected series of patients. Therefore the incidence of ACA measured using an enzyme linked immunosorbent assay (ELISA) technique validated against International Workshop standards7 in an unselected series of patients with connective tissue disease, and the possible associations with livedo reticularis and cerebrovascular disease, were sought.
Patients and methods
Ninety eight patients (13 male, 85 female) fulfilling American Rheumatism Association (ARA) criteria for SLE8 were studied. All were being followed up at a connective tissue disease clinic serving as a Accepted for publication 25 July 1987. Correspondence to Dr N J McHugh, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath BA1 1RL, Avon, England. referral base for a large region of south west England. In addition to a comprehensive clinical and serological profile that had already been recorded, an examination of hospital records was made. Renal disease was defined as the presence of three or more of the following in the absence of other causes: persistent proteinuria greater than 0-5 g/24 hours; oedema requiring diuretic therapy; granular casts; creatinine clearance less than 60 ml/min; persistently raised serum creatinine greater than 124 [tmol/l; a diastolic blood pressure greater than 90 mmHg. Recurrent fetal loss was defined as two or more unexplained fetal losses. Serum was also studied from 66 patients fulfilling proposed criteria for progressive systemic sclerosis,9 27 patients with Felty's syndrome, 12 
Results
Twenty three of 98 patients (23%) with SLE had raised IgG ACA (i.e., greater than 2SD above the mean of 100 normal sera) (Fig. 1) . Low levels were found in three patients (5%) with systemic sclerosis, and one patient with Felty's syndrome who also had thrombotic thrombocytopenic purpura. All patients with chronic localised cutaneous lupus or idiopathic valvular heart disease had normal levels. Moderately increased levels were found in three (19%) false positive VDRL sera. Increased IgM ACA were Anticardiolipin antibody levels in SLE 111 less prevalent (5%) in SLE and correlated weakly with serum IgM (r=0-328, p<0.05). Increased IgM ACA were found in 2% (systemic sclerosis) to 13% (false positive VDRL) of other control groups.
The clinical associations of increased IgG ACA were with major cerebrovascular events and with livedo reticularis (Table 1) . Although there was no significant association with cerebral involvement as defined by ARA criteria8 (i.e., the occurrence of seizures or psychosis), there was a highly significant association of increased IgG ACA with the occurrence of cerebrovascular accidents (p=0.001, MannWhitney U test). Four patients had major cerebrovascular events, and all had increased IgG ACA, the two with the highest levels being men ( Table 2) . These events all occurred at a young age (range 25-33) and are described below. Visual evoked potentials were reduced and delayed. He responded well to treatment, initially with pulse methylprednisolone and cyclophosphamide, followed by oral prednisolone and azathioprine, but had residual cerebellar and pyramidal dysfunction, and hypertension requiring treatment with captopril. The following year he developed a photosensitive rash on the face, hands, and feet, which showed typical changes of SLE when biopsied.
CASE B
In 1986 this 33 year old man was first admitted with symptoms of arthralgia, weight loss, and central Of nine SLE patients with livedo reticularis, six had increased IgG ACA levels (p=0004, MannWhitney U test). Two of these had major cerebrovascular events coincident with the first record of the livedo, and the other four had renal disease. Of the other three patients with livedo reticularis and normal IgG ACA levels, two had renal involvement and the other hypertension. Livedo reticularis was strongly associated with renal disease (x2; p<0-001) and also with cerebrovascular involvement (X2; p<0-05). The renal disease in the six patients with livedo reticularis included heavy proteinuria, active urinary sediment, and in the four cases that were biopsied, active glomerulonephritis. IgG ACA alone were not associated with renal disease.
A complete obstetric history was obtained by either questionnaire or interview for 69 out of 85 women with SLE ( 
